| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |